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QT correction formulas based on heart rate
Bazett's QTc¼ QT/ORR
Fridericia QTc¼ QT/3ORR
Hodges QTc¼ QT+0.384x(60-HR)
Framingham QTc¼ QT+0.154x(1000-RR)
Nomogram If RR>1000; QTc¼ QT+0.116x(1000-RR)If 600<RR<1000; QTc¼
QT+0.156x(1000-RR) If 600<RR; QTc¼ QT+0.384x(1000-RR)
HR: heart rate
ECG measurements (meanSD) (msec)
RR slowest 957  344
QT fastest 341  63
QT slowest 443  72
JT fastest 214  50
JT slowest 304  54
JTa fastest 127  33
JTa slowest 188  43
TaTe fastest 82  20
TaTe slowest 111  28
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the generation of AF. Nasal continuous positive airway pressure (CPAP) is an
effective and widely used method in the treatment of OSA. The purpose of the present
study is to evaluate the short-term effects of nasal continuous positive airway pressure
(CPAP) treatment on atrial electromechanical delay and p wave dispersion (Pd) in
patients with obstructive sleep apnea (OSA).
Methods: A total of 24 OSA patients diagnosed with polysomnography who were
planned to undergo CPAP therapy and 18 healthy subjects were included in the study. The
basal intra and interatrial electromechanic delays prior to onset of the therapy were
measured using Tissue Doppler Imaging (TDI). Pd was calculated on the basis of 12-lead
ECG. In order to evaluate the effects of CPAP therapy, the patients underwent a re-eval-
uation on the basis of TDIs and 12-lead ECGs 6 months after the initiation of the therapy.
Results: Interatrial, left intraatrial and right intraatrial electromechanical delays prior to
the therapy were found to be signiﬁcantly greater in OSA group compared with the
therapy group (39.28 vs. 21.12.8, p<0,001; 20.57.2 vs. 11.12, p¼0,003;
20.711vs. 102.6, p<0,001, respectively). Pdwas found to be increased inOSAgroup
comparedwith the healthy controls (447ms vs. 28.54ms, p<0,001). Compared with
the basal values, interatrial, left intraatrial and right intraatrial electromechanical delays
measuredwith TDI during the re-evaluation 6months after theCPAP therapywere found
to decrease (39.28 vs. 28.76.5 p<0,001; 20.57.2 vs. 15.65.1, p<0,002; 20.711
vs. 13.17.3, p<0.001, respectively). Suchdecreaseswere alsovalid for the post-therapy
Pd values, compared with the basal values (447 ms vs. 377, p<0.001).
Conclusıon: CPAP therapy decreases the likelihood of AF generation by improving
the electromechanical delay and P wave dispersion in patients with OSA.
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Background: There has been increasing interest in developing non-invasive methods
to assess ventricular arythmias and the risk of sudden cardiac arrest. Certain elec-
trocardiographic repolarization indexes are valuable in determining prognosis of
healthy individuals. Increases in the heart rate shortens the QT interval. Thus, many
methods have been developed to correct the QT interval to account for changes in the
heart rate. In this study, we evaluated ﬁve different heart rate QT correction formulas
in patients with ischemic-hypoxic brain injury.
Methods: Forty patients with ischemic-hypoxic encephalopathy (21 male, 19 female;
mean age 6018 years) were enrolled in the study.While hypoxia was caused by cardio-
pulmonary resuscitation (CPR) in thirty-seven patients (92.5%), three patients (7.5%)
experienced hypoxia from other causes. Coronary revascularization had been given to 11
patients (27.5%) previously. QT, JT, JTa, TaTe intervalsweremeasured over 24 hours by
ambulatory ECG monitoring measuring the slowest and fastest heart rates (Table 1).
These measured repolarization parameters were adjusted using 5 different correction
formulas and distinctions between these correction formulas were evaluated (Table 2).
Results: The Fridericia method was least affected by heart rate in particular the QT
(419  51 msec, 451  49 msec) and TaTe (103  33 msec, 115  23 msec) during
the fastest and slowest heart rates. For the parameters JT (292  50 msec, 309  38
msec) and JTa (198  33 msec, 201  53 msec), the Framingham method gave the
most accurate results. What should be the upper limit of the QT interval? This
question remains important; because, the 450 msec limit for males and 470 msec limit
for females has been calculated using the Bazett's formula. While it is now clear that
the Bazett's formula does not correct the QT interval safely. For example, in our study,
the number out of 40 patients with long QT interval was 20 patients by the Bazett's
formula and 35 patients by the Nomogram formula during fastest heart rate (longer
than 450 msec for male, longer than 470 msec for female). Whereas according to the
Fridericia method, the number of patients with long QT interval was nine. We found
that at high heart rates, the Bazett's and Nomogram methods were inadequate for
determining long QT intervals. Incorrect long QT interval diagnoses are made
according to QT intervals calculated using the Bazett's and Nomogram methods and
based on this medications are chosen. Hence, caution should be used with QT
intervals calculated using these two methods especially in higher heart rates.
Conclusıons: In this study, the Bazett's formula, which is the most commonly used
correction method, was insufﬁcient to correct the ventricular repolarization parame-
ters. The Fridericia formula was the least affected by heart rate and gave more accurate
results than Bazett's formula in determining the QT and TaTe intervals.C152 JACC VoPP-183
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Objectıves: Beta thalassemia major, which causes chronic hemolytic anemia, is an
inherited hemoglobin disorder. The treatment with chelating agents are shown
improvement, but repeated blood transfusions, continue to lead to iron overload and
dysfunction of organs. In these patients, the leading causes of death are heart failure
and arrhythmias, so cardiac iron overload monitoring is essential. Cardiac MRI T2 *
values, recommended for the evaluation of iron overload in the heart, this is a tech-
nique that can be trusted, but the high cost and difﬁcult. The objective in this study, is
investigation of the importance of fragmented QRS (fQRS) and the relationship
between cardiac T2 * values in assessment of cardiac iron overload.
Methods: In this study, patients between the ages of 15-40 with a diagnosis of
thalassemia major were enrolled. In these patients, cardiac MRI T2 * values and
ECGs, were evaluated annually. Cardiac T2 * value of less than 20, was considered as
cardiac iron overload. Initial studies reported of fQRS, can be used for the evaluation
of scarring and ﬁbrosis, fragmented QRS was deﬁned as an additional spike of QRS
complexes without bundle branch block. The relationship was investigated, between
cardiac T2 * values and the presence of fragmented QRS in ECG.
Results: This study included a total of 103 patients (46 males, 57 females) follow up
with diagnosis of beta thalassemia major in our center. The mean age of the patients
was 22.6  6.6. All of the patients were receiving regular blood transfusions and iron
chelator. For patients with coronary artery disease, had no risk factors other than
smoking. 50 patients (48%), fQRS detected, 37 of them (74%), T2 * values were
found to below. Accordingly, the presence of fQRS, low T2 * value to predict the
sensitivity of 86.0% and speciﬁcity of 78.3%, respectively.
Conclusıon: Cardiac involvement is the main cause of mortality, early diagnosis of
cardiac dysfunction is vital in patients with beta thalassemia major. In these patients,
researching the presence of fQRS on surface ECG, especially in cardiac T2 * value
that cannot be follow-up in patients, regulation of treatment, due to cheap and easy
method, must be considered.
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Aim: Smokeless tobacco can be found in preparations for chewing or for being
absorbed by nasal and oral mucosae. In Turkey a type of smokeless tobacco called
Maras Powder (MP) is widely used in the southeastern region. The purpose of this
study was to investigate whether MP damages intra- and interatrial conduction delay
and left atrial (LA) mechanical functions as much as cigarette smoking.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
Left atrial volume measurements in smoking, Maras powder patients and
control groups.
Group I
Control group
(n¼50)
Group II
Patients with
smoking
(n¼50)
Group III
Patients with
Maras powder
(n¼50)
Left atrial maximal
volume (cm3/m2)
22.95.3 21.76.2 23.35.5
Left atrial minimal
volume (cm3/m2)
8.93.4 7.82.8 9.23.2
The volume at the onset of
atrial systole (cm3/m2)
14.74.7 14.54.8 16.44.3
Left atrial passive emptying
volume (cm3/m2)
8.23.2 7.13.4 6.94.3
Left atrial passive emptying
fraction (%)
0.360.11 0.320.12 0.280.14*
Left atrial active emptying
volume (cm3/m2)
5.82.2 6.83.0 7.22.5 #Method: A total of 150 consecutive chronic MP users (50 male with a mean age of
32.55.4 years), cigarette smokers (50 male with a mean age of 32.16.0 years) and
controls (50 male with a mean age of 30.15.8 years) were included in the study. Left
atrial volumes were measured echocardiographically according to biplane area–length
method in apical four-chamber and two-chamber views. Atrial electromechanical
coupling was measured with TDI. LA mechanical function parameters were
calculated.
Result: LA passive emptying fraction and LA active emptying volume was signiﬁ-
cantly decreased in MP groups than control groups (p¼0.012 and, p¼0.024, respec-
tively) and LA active emptying fraction were signiﬁcantly increased in cigarette
smoking groups than control groups (p¼0.003). There were the positive correlation
between the amount of MP and smoking (pack years) with LA active emptying
volume (r¼0.30, p¼0.002). PA lateral was signiﬁcantly higher in patients with MP
users than controls and PA septum was statistically higher in patients with cigarette
smokers (p¼0.04 and p¼0.05, respectively). The amount of MP and smoking (pack
years) was correlated with PA lateral, PA septum and interatrial electromechanical
delay (r¼0.48, p<0.001, r¼0.60, p<0.001 and r¼0.66, p<0.001, respectively).
Conclusıon: The main ﬁnding of this study is that some of the parameters of the atrial
electromechanical coupling intervals and left atrial mechanical function were found
signiﬁcantly lower in MP users group and cigarette smokers group compared to healthy
users whereas there was no signiﬁcant difference between the MP users and cigarette
smokers group.Also, the amount ofMPandcigarette (pack years)was correlatedwithPA
lateral, PA septum, interatrial electromechanical delay and LA active emptying volume.Clinical characteristics, laboratory and echocardiographic ﬁndings of the
groups
Group I
Control group
(n¼50)
Group II
Patients with
smoking (n¼50)
Group III
Patients with
Maras powder
(n¼50)
Age (years) 30.15.8 32.16 32.55.4
BMI (kg/m2) 26.33.7 25.93.5 26.93.9
BSA (m2) 1.960.14 1.950.15 1.920.16
Systolic BP (mmHg) 125.37.4 121.26.4 120.78.3
Diastolic BP (mmHg) 79.56.3 78.55.4 77.95.8
LV EDD (mm) 48.73.1 47.72.5 48.63.4
LV EF (%) 69.82.6 68.43.2 683.4
IVS 9.50.8 9.90.8 9.80.8
LA dimension (mm) 33.23.1 32.92.7 34.33.1
Mitral E velocity (cm/s) 78.914.5 78.514.8 81.016.7
Mitral A velocity (cm/s) 57.312.9 56.710.9 56.410.3
E/A 1.440.38 1.410.28 1.460.32
sPAP (mmHg) 19.53.8 19.43.9 21.13.5
Glucose (mg/dl) 92.715.7 92.816.6 93.719.8
Total cholesterol (mg/dl) 184.541.4 180.546.8 174.035
Triglycerides (mg/dl) 15188.2 173.7112.4 186.6130
HDL-cholesterol (mg/dl) 42.88.7 39.29.1 39.88.8
LDL-cholesterol (mg/dl) 110.234.6 106.936.5 10027.7
duration
(pocket years)
13.66.2 10.96.6
BMI body mass index, BSA body surface area, BP blood pressure, LV Left ventricular, LVEDD
LV end-diastolic dimension, EF ejection fraction, HDL High density lipoproteins, LDL low-
density-lipoprotein, All p values > 0.05 (ANOVA test)
Findings of atrial electromechanical coupling measured by tissue Doppler
imaging
Group I
Control group
(n¼50)
Group II
Patients with
smoking (n¼50)
Group III
Patients with
Maras powder
(n¼50)
Lateral PA (ms) 48.39.8 53.912.9 54.114.1 x
Septal PA (ms) 40.18.7 46.313.3 # 45.815.2
RV PA (ms) 34.18.4 38.49.9 37.512.7
Lateral PA-RV PA (ms) * 14.28.9 15.510.1 16.58.4
Septal PA- RV PA (ms) ** 6.05.9 7.98.8 8.27.7
#: p¼0.043 versus group 1 x: p¼0.054 versus group 1 PA: The interval with tissue Doppler
imaging, from the onset of P wave on the surface electrocardiogram to the beginning of the
late diastolic wave (Am wave). *Interatrial and **intra-atrial electromechanical delays
Left atrial active emptying
fraction (%)
0.39 0.10 0.460.10 U 0.43 0.11
Left atrial total emptying
volume (cm3/m2)
14.03.3 13.94.6 14.14.2
Left atrial total emptying
fraction (%)
0.610.9 0.630.9 0.61.0
*: p ¼ 0.012 versus group I #: p ¼ 0.024 versus group I U: p ¼ 0.003 versus group I
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Purpose: Patients on chronic warfarin therapy who have poor anticoagulation control
are at increased risk for adverse events. The aim of this study was to examine the
relationship between patient educational level (EL) and anticoagulation control as
measured by ‘International Normalized Ratio (INR)’.
Methods: 139 patients (mean age 65.910.4 years) who had visited the outpatient
cardiology clinic of a university hospital while receiving warfarin were investigated.
Patients with cognitive or neurological deﬁcits were excluded. Demographic and
clinical data (including anticoagulation indication and duration, target INR range, and
last 6 INR values) were collected. Good anticoagulation control (GAC) was deﬁned as
achieving target INR value in at least 60% of measurements. Patients were grouped
according to their EL as illiterate (group 1, n¼34), 5 years of education (group 2,
n¼66), >5 years of education (group 3, n¼39).
Results: The majority of patients were female (n¼86, 62.3%), and the most frequent
warfarin indication was nonvalvular atrial ﬁbrillation (n¼116, 84%). Most patients
(80%) have been treated for at least 1 year. Only 44.6% of participants had good
anticoagulation control. Patients in group 1 were older (71.48.9 vs. 62.211.2,
p<0.001) and more likely to be female (76.5% vs. 51.3%, P¼0.023), compared to
group 3. There were no differences regarding warfarin indication and duration of
therapy between groups (p¼0.118, and p¼0.413 respectively). There was no signif-
icant relationship between EL and anticoagulation control (p¼0.464).
Conclusıon: Although there was tendency of better anticoagulation control in the
educated patients (Group 3) this is not reach to a signiﬁcant level. It is obvious that
anticoagulation control remains to be improved.Characteristics of the patients
Group 1
n ¼ 34
Group 2
n ¼ 66
Group 3
n ¼ 39 P value
Age 71.4  8.9 65.3  9.5 62.2  11.2 < 0.001
Female (%) 26 (76.5) 41 (62.1) 20 (51.3) 0.085
Nonvalvular AF (%) 32 (94.1) 49 (77.8) 29 (80.6) 0.118
GAC 13 (38.2) 30 (45.5) 19 (48.7) 0.656
Duration of warfarin
treatment (months)
34.0  29.8 42.9  48.1 49.2  40.7 0.413
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